Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/14304
Title: | Relation between diabetes, metformin treatment and the occurrence of malignancies in a Belgian primary care setting | Authors: | Ngwana, Geraldine AERTS, Marc Truyers, Carla Mathieu, Chantal Bartholomeeusen, Stefaan WAMI, Welcome Buntinx, Frank |
Issue Date: | 2012 | Publisher: | ELSEVIER IRELAND LTD | Source: | DIABETES RESEARCH AND CLINICAL PRACTICE, 97 (2), p. 331-336 | Abstract: | Background: Associations between type 2 diabetic patients and a higher risk of developing cancer have been reported worldwide. Recently, a protective effect of metformin has been described. Aim: To examine in the Belgian primary care population the relation between presence of type 2 diabetes with and without metformin treatment and the occurrence of malignancies. Design of study: Retrospective cohort study, based on the Intego database, an ongoing Belgian general practice-based morbidity registry, covering 90 general practitioners and including about 1.5 million patient-years between 1994 and 2008. Method: Cox proportional hazard analysis comparing emergence of malignancy in patients with and without type 2 diabetes, and among patients with diabetes comparing emergence of malignancy in those treated with various antidiabetic drugs. Results: Malignancies occurred more in type 2 diabetic patients compared to non-diabetic controls (HR = 1.84; 95% CI = 1.51-2.24), adjusted for age, gender and weight. Treatment with both metformin and 'other' antidiabetic agents was related to decreased cancer risk (HR = 0.24 and 0.22) compared to diet only in men but not in women. Conclusion: In this Belgian primary care setting, diabetic patients have higher cancer prevalences than non-diabetic patients. Moreover, in diabetic men, not only metformin but also other antidiabetic agents were associated with lower cancer risks. (C) 2012 Elsevier Ireland Ltd. All rights reserved. | Notes: | Frank, B (reprint author),ACHG KULeuven, Kapucijnenvoer 33,Blok J,Bus 7001, B-3000 Louvain, Belgium. [Show the Organization-Enhanced name(s)] [Geraldine, Ngwana; Marc, Aerts; Welcome, Wami] Univ Hasselt, Ctr Stat, Hasselt, Belgium. [Carla, Truyers; Stefaan, Bartholomeeusen] Katholieke Univ Leuven, Dept Gen Practice, Louvain, Belgium. [Chantal, Mathieu] Katholieke Univ Leuven, Dept Endocrinol, Louvain, Belgium. [Frank, Buntinx] Maastricht Univ, Caphri Res Sch, Maastricht, Netherlands. frank.buntinx@med.kuleuven.be | Keywords: | Endocrinology & Metabolism; cohort studies; type 2 diabetes; malignancy; metformin; Cox regression;Cohort studies; Type 2 diabetes; Malignancy; Metformin; Cox regression | Document URI: | http://hdl.handle.net/1942/14304 | ISSN: | 0168-8227 | e-ISSN: | 1872-8227 | DOI: | 10.1016/j.diabres.2012.02.002 | ISI #: | 000307823400028 | Category: | A1 | Type: | Journal Contribution | Validations: | ecoom 2013 |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
geraldine 1.pdf Restricted Access | Published version | 427.52 kB | Adobe PDF | View/Open Request a copy |
SCOPUSTM
Citations
16
checked on Sep 2, 2020
WEB OF SCIENCETM
Citations
19
checked on Apr 14, 2024
Page view(s)
100
checked on Sep 7, 2022
Download(s)
80
checked on Sep 7, 2022
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.